Literature DB >> 20625273

Recruitment of a community-based cohort for research on diversity and risk of dementia.

Ladson Hinton1, Kimberly Carter, Bruce R Reed, Laurel Beckett, Esther Lara, Charles DeCarli, Dan Mungas.   

Abstract

We describe the history, development, and success of the recruitment and screening procedures used by researchers at the University of California, Davis Alzheimer's Disease Center (UCD ADC) to facilitate minority enrollment in research. After an initial, unsuccessful approach with satellite clinics in minority neighborhoods, the ADC shifted to an active community outreach approach. Multiple strategies were implemented to remove barriers to research participation such as providing transportation to clinical appointments and offering in-home cognitive screening. Considerable resources were directed toward hiring and training bicultural and bilingual individuals with knowledge of the target populations, both as recruiters and staff involved in clinical assessment. Implementation of these methods resulted in a dramatic increase in the number of ethnic minorities enrolled (and retained) in research protocols, including protocols that are complex and longitudinal. Diversity was achieved on other variables as well; years of education in the cohort range from 0 to 21, with 26% having 8 years or less. The community screen identified candidates for an in depth clinical evaluation and enrollment in longitudinal research, and we examined factors that predicted a positive response to invitation for the clinical evaluation. Individuals with a broader fund of knowledge were more likely to participate independent of other variables including ethnicity and education. When diversity is an important goal active outreach is far more efficacious than clinic-based and advertising-based approaches to recruitment.

Entities:  

Mesh:

Year:  2010        PMID: 20625273      PMCID: PMC2946798          DOI: 10.1097/WAD.0b013e3181c1ee01

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  27 in total

1.  Spanish and English Neuropsychological Assessment Scales (SENAS): further development and psychometric characteristics.

Authors:  Dan Mungas; Bruce R Reed; Paul K Crane; Mary N Haan; Hector González
Journal:  Psychol Assess       Date:  2004-12

2.  Criterion-referenced validity of a neuropsychological test battery: equivalent performance in elderly Hispanics and non-Hispanic Whites.

Authors:  Dan Mungas; Bruce R Reed; Sarah Tomaszewski Farias; Charles DeCarli
Journal:  J Int Neuropsychol Soc       Date:  2005-09       Impact factor: 2.892

3.  Culturally attuned recruitment, retention, and adherence in Alzheimer disease and associated disorders: a best practices working model.

Authors:  Ramón Valle
Journal:  Alzheimer Dis Assoc Disord       Date:  2005 Oct-Dec       Impact factor: 2.703

Review 4.  Drug development, clinical trials, cultural heterogeneity in Alzheimer disease: the need for pro-active recruitment.

Authors:  Lon S Schneider
Journal:  Alzheimer Dis Assoc Disord       Date:  2005 Oct-Dec       Impact factor: 2.703

Review 5.  Effective recruitment and retention of minority research participants.

Authors:  Antronette K Yancey; Alexander N Ortega; Shiriki K Kumanyika
Journal:  Annu Rev Public Health       Date:  2006       Impact factor: 21.981

Review 6.  Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review.

Authors:  Jean G Ford; Mollie W Howerton; Gabriel Y Lai; Tiffany L Gary; Shari Bolen; M Chris Gibbons; Jon Tilburt; Charles Baffi; Teerath Peter Tanpitukpongse; Renee F Wilson; Neil R Powe; Eric B Bass
Journal:  Cancer       Date:  2008-01-15       Impact factor: 6.860

7.  Recruiting African-American older adults for a community-based health promotion intervention: which strategies are effective?

Authors:  E A Coleman; L Tyll; A Z LaCroix; C Allen; S G Leveille; J I Wallace; D M Buchner; L C Grothaus; E H Wagner
Journal:  Am J Prev Med       Date:  1997 Nov-Dec       Impact factor: 5.043

Review 8.  Recruiting vulnerable populations into research: a systematic review of recruitment interventions.

Authors:  Stacy J UyBico; Shani Pavel; Cary P Gross
Journal:  J Gen Intern Med       Date:  2007-03-21       Impact factor: 5.128

9.  Gaining and sustaining minority participation in longitudinal research projects.

Authors:  M A Gauthier; W P Clarke
Journal:  Alzheimer Dis Assoc Disord       Date:  1999 Apr-Jun       Impact factor: 2.703

Review 10.  Why are African Americans under-represented in medical research studies? Impediments to participation.

Authors:  V L Shavers-Hornaday; C F Lynch; L F Burmeister; J C Torner
Journal:  Ethn Health       Date:  1997 Mar-Jun       Impact factor: 2.772

View more
  57 in total

1.  Cooccurrence of vascular risk factors and late-life white-matter integrity changes.

Authors:  Pauline Maillard; Owen T Carmichael; Bruce Reed; Dan Mungas; Charles DeCarli
Journal:  Neurobiol Aging       Date:  2015-01-14       Impact factor: 4.673

2.  The contributions of MRI-based measures of gray matter, white matter hyperintensity, and white matter integrity to late-life cognition.

Authors:  J He; V S S Wong; E Fletcher; P Maillard; D Y Lee; A-M Iosif; B Singh; O Martinez; A E Roach; S N Lockhart; L Beckett; D Mungas; S T Farias; O Carmichael; C DeCarli
Journal:  AJNR Am J Neuroradiol       Date:  2012-04-26       Impact factor: 3.825

3.  Early life development in a multiethnic sample and the relation to late life cognition.

Authors:  Rebecca J Melrose; Paul Brewster; María J Marquine; Anna MacKay-Brandt; Bruce Reed; Sarah T Farias; Dan Mungas
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2014-01-03       Impact factor: 4.077

4.  Loss of fornix white matter volume as a predictor of cognitive impairment in cognitively normal elderly individuals.

Authors:  Evan Fletcher; Mekala Raman; Philip Huebner; Amy Liu; Dan Mungas; Owen Carmichael; Charles DeCarli
Journal:  JAMA Neurol       Date:  2013-11       Impact factor: 18.302

5.  Education amplifies brain atrophy effect on cognitive decline: implications for cognitive reserve.

Authors:  Dan Mungas; Brandon Gavett; Evan Fletcher; Sarah Tomaszewski Farias; Charles DeCarli; Bruce Reed
Journal:  Neurobiol Aging       Date:  2018-04-12       Impact factor: 4.673

6.  Neuropathological Diagnoses of Demented Hispanic, Black, and Non-Hispanic White Decedents Seen at an Alzheimer's Disease Center.

Authors:  Teresa Jenica Filshtein; Brittany N Dugger; Lee-Way Jin; John M Olichney; Sarah T Farias; Luis Carvajal-Carmona; Paul Lott; Dan Mungas; Bruce Reed; Laurel A Beckett; Charles DeCarli
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

7.  GeneMatch: A novel recruitment registry using at-home APOE genotyping to enhance referrals to Alzheimer's prevention studies.

Authors:  Jessica B Langbaum; Jason Karlawish; J Scott Roberts; Elisabeth M Wood; Angela Bradbury; Nellie High; Trisha L Walsh; David Gordon; Raj Aggarwal; Peter Davis; Carter Stowell; Lane Trisko; Carolyn M Langlois; Eric M Reiman; Pierre N Tariot
Journal:  Alzheimers Dement       Date:  2019-02-13       Impact factor: 21.566

8.  Vascular Burden Score Impacts Cognition Independent of Amyloid PET and MRI Measures of Alzheimer's Disease and Vascular Brain Injury.

Authors:  Charles DeCarli; Sylvia Villeneuve; Pauline Maillard; Danielle Harvey; Baljeet Singh; Owen Carmichael; Evan Fletcher; John Olichney; Sarah Farias; William Jagust; Bruce Reed; Dan Mungas
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 9.  Facilitating Alzheimer disease research recruitment.

Authors:  Joshua D Grill; James E Galvin
Journal:  Alzheimer Dis Assoc Disord       Date:  2014 Jan-Mar       Impact factor: 2.703

10.  Life experience and demographic influences on cognitive function in older adults.

Authors:  Paul W H Brewster; Rebecca J Melrose; María J Marquine; Julene K Johnson; Anna Napoles; Anna MacKay-Brandt; Sarah Farias; Bruce Reed; Dan Mungas
Journal:  Neuropsychology       Date:  2014-06-16       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.